India's Pharmaceutical Exports

Country Profile

Bosnia and Herzegovina

Bosnia and Herzegovina is a developing market for Indian pharmaceuticals — $3.44M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $88K. The compound annual growth rate since FY2016 stands at 13.5%.

🇧🇦 $3.44M · 3.6× growth since FY2016 · 13.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.44M
Exports FY2025–26 DGCIS
3.6×
Growth FY2016→2026
13.5%
CAGR FY2016→2026
73%
Medicines Share
5
Product Categories Supplied
Bosnia and Herzegovina is a developing market for Indian pharmaceuticals — $3.44M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $88K. The compound annual growth rate since FY2016 stands at 13.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.52M (73.4%) Medicine Ingredients $550K (16.0%) Surgical & Hospital Supplies $258K (7.5%) Vaccines $88K (2.6%) Traditional & Herbal $19K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bosnia and Herzegovina in the RBI overseas direct investment dataset (2011–2026).